BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23986199)

  • 21. Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice.
    van de Steeg E; van Esch A; Wagenaar E; Kenworthy KE; Schinkel AH
    Clin Cancer Res; 2013 Feb; 19(4):821-32. PubMed ID: 23243220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profile of the anti-sickling hydroxyurea in wild-type and transgenic sickle cell mice.
    Iyamu WE; Lian L; Asakura T
    Chemotherapy; 2001; 47(4):270-8. PubMed ID: 11399864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.
    van de Steeg E; Wagenaar E; van der Kruijssen CM; Burggraaff JE; de Waart DR; Elferink RP; Kenworthy KE; Schinkel AH
    J Clin Invest; 2010 Aug; 120(8):2942-52. PubMed ID: 20644253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic account of distinct change in organic anion transporting polypeptide 1B (OATP1B) substrate pharmacokinetics during OATP1B-mediated drug-drug interactions using physiologically-based pharmacokinetic modeling.
    Hegde PV; Morse BL
    Drug Metab Dispos; 2024 May; ():. PubMed ID: 38740464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.
    Sticova E; Lodererova A; van de Steeg E; Frankova S; Kollar M; Lanska V; Kotalova R; Dedic T; Schinkel AH; Jirsa M
    Int J Clin Exp Pathol; 2015; 8(5):5252-62. PubMed ID: 26191226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method.
    Chan GH; Houle R; Zhang J; Katwaru R; Li Y; Chu X
    Drug Metab Dispos; 2023 Sep; 51(9):1089-1104. PubMed ID: 37137718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of the OATP1B subfamily to cancer biology and treatment.
    Sissung TM; Reece KM; Spencer S; Figg WD
    Clin Pharmacol Ther; 2012 Nov; 92(5):658-60. PubMed ID: 23010650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
    van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
    Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
    Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
    Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
    Farasyn T; Pahwa S; Xu C; Yue W
    Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions.
    Kunze A; Ediage EN; Dillen L; Monshouwer M; Snoeys J
    Clin Pharmacokinet; 2018 Dec; 57(12):1559-1570. PubMed ID: 29663259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.
    Dong M; McGann PT; Mizuno T; Ware RE; Vinks AA
    Br J Clin Pharmacol; 2016 Apr; 81(4):742-52. PubMed ID: 26615061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
    Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
    Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel.
    Mori D; Ishida H; Mizuno T; Kusumoto S; Kondo Y; Izumi S; Nakata G; Nozaki Y; Maeda K; Sasaki Y; Fujita KI; Kusuhara H
    Drug Metab Dispos; 2020 May; 48(5):387-394. PubMed ID: 32114508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.
    Higgins JW; Bao JQ; Ke AB; Manro JR; Fallon JK; Smith PC; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2014 Jan; 42(1):182-92. PubMed ID: 24194513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
    Smith NF; Figg WD; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.
    Takita H; Scotcher D; Chu X; Yee KL; Ogungbenro K; Galetin A
    Clin Pharmacol Ther; 2022 Sep; 112(3):615-626. PubMed ID: 35652251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
    Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
    J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions.
    Kimoto E; Costales C; West MA; Bi YA; Vourvahis M; David Rodrigues A; Varma MVS
    Clin Pharmacol Ther; 2022 Feb; 111(2):404-415. PubMed ID: 34605015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
    de Graan AJ; Lancaster CS; Obaidat A; Hagenbuch B; Elens L; Friberg LE; de Bruijn P; Hu S; Gibson AA; Bruun GH; Corydon TJ; Mikkelsen TS; Walker AL; Du G; Loos WJ; van Schaik RH; Baker SD; Mathijssen RH; Sparreboom A
    Clin Cancer Res; 2012 Aug; 18(16):4433-40. PubMed ID: 22711709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.